|
1
|
Bray F, Loos AH, Oostindier M and
Weiderpass E: Geographic and temporal variations in cancer of the
corpus uteri: Incidence and mortality in pre- and postmenopausal
women in Europe. Int J Cancer. 117:123–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Murray T, Ward E, Samuels A,
Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics,
2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sant M, Aareleid T, Berrino F, Bielska
Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T,
Møller H, et al: EUROCARE-3: Survival of cancer patients diagnosed
1990–94-results and commentary. Ann Oncol. 14(Suppl 5): S61–S118.
2003. View Article : Google Scholar
|
|
5
|
Creasman W: Revised FIGO staging for
carcinoma of the endometrium. Int J Gynaecol Obstet. 105:1092009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greer BE, Koh WJ, Abu-Rustum N, Bookman
MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth
W, et al: Uterine cancers. J Natl Compr Canc Netw. 4:438–462.
2006.PubMed/NCBI
|
|
7
|
Cragun JM, Havrilesky LJ, Calingaert B,
Synan I, Secord AA, Soper JT, Clarke-Pearson DL and Berchuck A:
Retrospective analysis of selective lymphadenectomy in apparent
early-stage endometrial cancer. J Clin Oncol. 23:3668–3675. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Jia L, Zhang Q, Zhang Y, Yang X
and Kong B: Therapeutic role of systematic retroperitoneal
lymphadenectomy in endometrial cancer. Bull Cancer. 99:E10–E17.
2012.PubMed/NCBI
|
|
9
|
Benedetti Panici P, Basile S, Maneschi F,
Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S,
Mangili G, Katsaros D, et al: Systematic pelvic lymphadenectomy vs.
no lymphadenectomy in early-stage endometrial carcinoma: Randomized
clinical trial. J Natl Cancer Inst. 100:1707–1716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
ASTEC study group. Kitchener H, Swart AM,
Qian Q, Amos C and Parmar MK: Efficacy of systematic pelvic
lymphadenectomy in endometrial cancer (MRC ASTEC trial): A
randomised study. Lancet. 373:125–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morrow CP, Bundy BN, Kurman RJ, Creasman
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: A Gynecologic Oncology Group
study. Gynecol Oncol. 40:55–65. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Achouri A, Huchon C, Bats AS, Bensaid C,
Nos C and Lécuru F: Complications of lymphadenectomy for
gynecologic cancer. Eur J Surg Oncol. 39:81–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. Ann Intern Med.
151:264–269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Green S, Higgins JPT, Alderson P, Clarke
M, Mulrow CD and Oxman AD: Cochrane Handbook for Systematic Reviews
of Interventions. Version 5.0.2.The Cochrane Book Series. John
Wiley & Sons, Ltd. (Hoboken, NJ). 2008.
|
|
15
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bassarak N, Blankenstein T, Brüning A,
Dian D, Bergauer F, Friese K and Mylonas I: Is lymphadenectomy a
prognostic marker in endometrioid adenocarcinoma of the human
endometrium? BMC Cancer. 10:2242010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ceccaroni M, Savelli L, Bovicelli A, Dian
D, Bergauer F, Friese K and Mylonas I: Prognostic value of pelvic
lymphadenectomy in surgical treatment of apparent stage I
endometrial cancer. Anticancer Res. 24:2073–2078. 2004.PubMed/NCBI
|
|
18
|
Chino JP, Jones E, Berchuck A, Secord AA
and Havrilesky LJ: The influence of radiation modality and lymph
node dissection on survival in early-stage endometrial cancer. Int
J Radiat Oncol Biol Phys. 82:1872–1879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dowdy SC, Borah BJ, Bakkum-Gamez JN,
Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A and Podratz KC:
Prospective assessment of survival, morbidity and cost associated
with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol.
127:5–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao Y, Yu A and Chen L: Place of value of
pelvic lymphadenectomy for treatment of endometrial neoplasms.
Zhonghua Fu Chan Ke Za Zhi. 35:264–266. 2000.(In Chinese).
PubMed/NCBI
|
|
21
|
Jeong NH, Lee JM, Lee JK, Kim MK, Kim YJ,
Cho CH, Kim SM, Park SY, Park CY and Kim KT: Role of systematic
lymphadenectomy and adjuvant radiation in early-stage endometrioid
uterine cancer. Ann Surg Oncol. 17:2951–2957. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang WD, Kim CH, Cho MK, Kim JW, Kim YH,
Choi HS and Kim SM: Lymphadenectomy for low-risk endometrial cancer
based on preoperative and intraoperative assessments. Int J Gynecol
Cancer. 19:657–661. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kilgore LC, Partridge EE, Alvarez RD,
Austin JM, Shingleton HM, Noojin F III and Conner W: Adenocarcinoma
of the endometrium: Survival comparisons of patients with and
without pelvic node sampling. Gynecol Oncol. 56:29–33. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji RY, Gao N, Li Y, Yang Y, Liu S and Yao
X: Clinical analysis of 116 cases of early stage endometrial
cancer. Chinese Journal of Clinical Oncology. 36:917–919. 2009.
|
|
25
|
Angioli R, Plotti F, Cafà EV, Dugo N,
Capriglione S, Terranova C, Montera R, Guzzo F and Panici PB:
Quality of life in patients with endometrial cancer treated with or
without systematic lymphadenectomy. Eur J Obstet Gynecol Reprod
Biol. 170:539–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan JK, Cheung MK, Huh WK, Osann K,
Husain A, Teng NN and Kapp DS: Therapeutic role of lymph node
resection in endometrioid corpus cancer: A study of 12,333
patients. Cancer. 107:1823–1830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lutman CV, Havrilesky LJ, Cragun JM,
Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL and Soper
JT: Pelvic lymph node count is an important prognostic variable for
FIGO stage I and II endometrial carcinoma with high-risk histology.
Gynecol Oncol. 102:92–97. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan JK and Kapp DS: Role of complete
lymphadenectomy in endometrioid uterine cancer. Lancet Oncol.
8:831–841. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mariani A, Webb MJ, Keeney GL, Aletti G
and Podratz KC: Predictors of lymphatic failure in endometrial
cancer. Gynecol Oncol. 84:437–442. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mariani A, Webb MJ, Keeney GL and Podratz
KC: Routes of lymphatic spread: A study of 112 consecutive patients
with endometrial cancer. Gynecol Oncol. 81:100–104. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lurain JR, Rice BL, Rademaker AW,
Poggensee LE, Schink JC and Miller DS: Prognostic factors
associated with recurrence in clinical stage I adenocarcinoma of
the endometrium. Obstet Gynecol. 78:63–69. 1991.PubMed/NCBI
|
|
32
|
Abu-Rustum NR, Iasonos A, Zhou Q, Oke E,
Soslow RA, Alektiar KM, Chi DS and Barakat RR: Is there a
therapeutic impact to regional lymphadenectomy in the surgical
treatment of endometrial carcinoma? Am J Obstet Gynecol. 198(457):
e451–455. 2008.(Discussion 457, e455–456).
|
|
33
|
Creasman WT, Morrow CP, Bundy BN, Homesley
HD, Graham JE and Heller PB: Surgical pathologic spread patterns of
endometrial cancer. A Gynecologic Oncology Group Study. Cancer.
60(8 Suppl): S2035–S2041. 1987. View Article : Google Scholar
|
|
34
|
Creasman WT, Mutch DE and Herzog TJ: ASTEC
lymphadenectomy and radiation therapy studies: Are conclusions
valid? Gynecol Oncol. 116:293–294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mariani A, Webb MJ, Galli L and Podratz
KC: Potential therapeutic role of para-aortic lymphadenectomy in
node-positive endometrial cancer. Gynecol Oncol. 76:348–356. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Todo Y, Kato H, Kaneuchi M, Watari H,
Takeda M and Sakuragi N: Survival effect of para-aortic
lymphadenectomy in endometrial cancer (SEPAL study): A
retrospective cohort analysis. Lancet. 375:1165–1172. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao L, Yang L, Lv X, Bu S, Wan F, Qian S,
Wei Q, Han P and Fan T: A systematic review and meta-analysis of
comparative studies on the efficacy of extended pelvic lymph node
dissection in patients with clinically localized prostatic
carcinoma. J Cancer Res Clin Oncol. 140:243–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Z, Chen JQ and Cao YF: Systematic
review of D2 lymphadenectomy versus D2 with para-aortic nodal
dissection for advanced gastric cancer. World J Gastroenterol.
16:1138–1149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brar SS, Seevaratnam R, Cardoso R, Law C,
Helyer L and Coburn N: A systematic review of spleen and pancreas
preservation in extended lymphadenectomy for gastric cancer.
Gastric Cancer. 15(Suppl 1): S89–S99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim HS, Suh DH, Kim MK, Chung HH, Park NH
and Song YS: Systematic lymphadenectomy for survival in patients
with endometrial cancer: A meta-analysis. Jpn J Clin Oncol.
42:405–412. 2012. View Article : Google Scholar : PubMed/NCBI
|
